EADV Podcast

Join Prof. Rolland Gyulai as he presents his selection of Editor’s Picks from the June 2026 issue: 

 

First oral TNFR1 inhibitor for mild-to-moderate psoriasis

Adjuvant treatment with immune checkpoint inhibitors - no benefit in acral melanomas

Simple biomarkers predict favourable treatment response

Mogamulizumab-associated rash – new insights into pathogenesis

Read the Editor's Picks here: https://onlinelibrary.wiley.com/doi/10.1111/jdv.70448

In this episode of the EADV Podcast, Dr. Antonio Torrelo speaks with Dr. Andrea Diociaiuti, contributor to the recent JEACP Special issue on cutaneous mosaicism, to explore one of the most fascinating concepts in dermatology and genetics. Together, they discuss how mosaicism shapes the skin, the clinical patterns that help physicians recognise these conditions, and how advances in genetic sequencing are transforming diagnosis and patient care. The conversation also delves into the broader implications of mosaicism beyond the skin, the importance of careful clinical observation, and the increasing potential of precision medicine and targeted therapies. This episode offers listeners an accessible and forward-looking overview of a rapidly evolving field that is changing the way dermatologists understand genetics, skin biology, and personalised medicine.

 

Read the Special Issue: https://onlinelibrary.wiley.com/toc/27686566/2025/4/3

Join Prof. Carle Paul as he presents his selection of Editor’s Picks from the May 2026 issue: 

Management of cutaneous immune adverse events associated with immune check point inhibitors (ICI)

Pregnancy-associated melanoma: no additional risk of progression

Long-term treatment with nemolizumab for atopic dermatitis

Management of cutaneous lupus: state of the art

 

Read the Editor's Picks here: https://onlinelibrary.wiley.com/doi/10.1111/jdv.70409

In this episode of the EADV Podcast, Dr. Azael Freites Martinez is joined by Prof. Zoe Apalla and Dr. Vincent Sibaud for a practical discussion on the dermatologic adverse events associated with immune checkpoint inhibitors. Together, they explore why the skin is so commonly affected, how to recognise the most frequent reactions in daily practice, and when cancer patients should be referred to a dermatologist.

The conversation also highlights current management strategies for pruritus, eczematous, psoriasiform and lichenoid reactions, with a focus on accurate diagnosis, multidisciplinary collaboration, and the growing role of targeted and biologic therapies in supportive oncodermatology.

The episode closes with an important reminder: many of these skin reactions are manageable, and timely dermatologic care can make a meaningful difference to both quality of life and cancer treatment continuity.

Join Sarah Walsh as she presents her selection of Editor’s Picks from the April 2026 issue:

Robust data supporting biologics in paediatric psoriasis

Economically encouraging results for biologics in hidradenitis suppurativa

News about scabies and tips for ticks!

Pain control in SJS/TEN may protect against PTSD

 

Read the Editor's Picks here: https://onlinelibrary.wiley.com/doi/10.1111/jdv.70342